| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| chlorprothixene | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | muscarinic acetylcholine receptor m5 | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.28 | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.41 | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | dopamine d3 receptor | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.63 | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | histamine h1 receptor | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.35 | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.31 | approved,experimental,investigational,withdrawn | antagonist |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.31 | approved,experimental,investigational,withdrawn | inhibitor,antagonist |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.31 | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.53 | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.47 | approved,experimental,investigational,withdrawn | inhibitor,antagonist |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank , DGIDB | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.47 | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| chlorprothixene | serotonin receptors | small molecule | NA | drugbank | Bipolar Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,experimental,investigational,withdrawn | inhibitor |
| click here to return to the previous page | ||||||||